|4.30||+0.10 / +2.38%|
Data as of 3:59pm ET
|4.30||0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 5.00. The median estimate represents a +39.53% increase from the last price of 4.30.
The current consensus among 4 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.